Results of a survey on the role of Patient Groups in Research and their priorities for the future Florence Paterson Centre de sociologie de l’innovation, UMR CNRS 7185 - Mines-ParisTech Paris, France
Transcript
1. Results of a survey on the role of Patient Groups in
Research and their priorities for the future Florence Paterson
Centre de sociologie de linnovation, UMR CNRS 7185 -
Mines-ParisTech Paris, France
2. 2010 Survey on Patient Organisations and Research
EURORDIS
and the
Centre de sociologie de linnovation
Fabrizia Bignami
Paloma Tejada
Franois Faurisson
Julia Fitzgerald
Anja Helm
Madeleine Akrich
Vololona Rabeharisoa
Florence Paterson
Frdric Vergnaud
Michel Callon
results from a joint collaboration between
3. A few words on the works of the Centre de sociologie de
linnovation
Contribution to Science and Technology Studies
understanding the rise of technical democracy
Forms of participation of civil society organizations in
scientific and technical activities and debates
impact on the modes of production of knowledge
and on scientific practices
upshot on the emergence and the increase of collective
mobilizations around science issues
4. Research questions
Lay knowledge and expertise
POs expertise: to what extend is the claim to hold an expertise
based on the mobilization of experiential knowledge coupled with
the acquisition of certified knowledge?
In what form do patients collectives mobilize experiential
knowledge & certified knowledge: alignment, opposition or
conjunction?
The role of knowledge in the governance of medical and health
policies, and the contribution of patient organizations
Mechanisms through which POs voice their concerns in
health-policy making
The ways POs promote their expertise capacity in health
policy-making
5. Aims of the Survey
To evaluate POs support to research: in what ways and to what
extent
To learn about POs experience of collaboration with
researchers
To collect POs opinion on priorities and obstacles for rare
disease research
6. Survey population
Questionnaire sent to 772 POs
309 responses from 29 European countries
(178 member + 131 non member POs)
= 40% response rate
7. General characteristics of participating POs
Age of the POs
Financial resources
Diseases and clinical domains concerned
Existence of internal Scientific Committees
8. Rare diseases POs: newly created organisations Number of
years active
37% exist for 10 to 15 years
22% exist for less than 5 years
9. Membership Number of members 2/3 of (non umbrella) POs have
less than 500 members Building its membership: a long-term process
44% of the POs created before 1970 have more than 3000 members
.
31% of the POs created between 2000 and 2009 have 50 to 150
members .
10. High diversity in POs annual budgets
of POs have less than 3 000
10% less than 300
6% no budget
of POs have more than 100 000 5% more than 1 200 000 100 000 3 000
25 000 0
12. Integration of external scientific competences within the
POs structure
56% of the POs have a Scientific Committee (174 out of
309)
A very common device within French POs
Greater proportion among older POs: 80% of the POs created
before 1980 vs. 60% after 1980
45% of the Scientific Committees contribute to the allocation
of financial resources for research
13. POs support to Research
37 % of POs fund research
but
POs non-financial support to research, less visible, provides
specific resources
14. Areas of research funded 81 % Basic research 57%
Therapeutics 56% Diagnosis 46% Human and Social Science 19%
Research infrastructures 54% Epidemiology / Natural history of the
disease 24% Assistance technologies / Daily life
15. Types of financial support (37% of the Pos) 47% Financing a
fellowship for a young researcher 54% Financing the acquisition of
a specific research equipment (centrifuge, computer, etc) 77%
Initiating and financing a specific research project 75%
Co-financing the operating budget of a specific research project
39% Co-financing meetings of researchers / clinicians 30%
Co-financing training of researchers / clinicians
16. Financial support to research is linked to the POs budgets
and age POs annual total budget % of POs funding research Budget
> 300.000 81% Budget between 30.000 to 300.000 50% - 56% Budget
between 5000 to 30.000 32% - 33% Budget < 5000 11% -14% Date of
creation % of POs funding research Before 1970 70% Between 1970 -
1979 61% Between 1980-1989 47% Between 1990 -1999 35% Between
2000-2009 30%
17. POs support to research 76% Actions aiming at creating
links between patients, researchers and physicians 49% Providing
information and counseling for potential participants in clinical
trials 57% Helping to identify patients to participate in clinical
trials 30% Participation in scientific committees within
institutions 45% Collaboration in clinical trials design 48%
Defining research projects by highlighting patients' needs and
expectations 28% Launching campaigns for the collection of
biological samples from patients
Non-financial support to research
Financial support to research: 37%
18. POs experience of collaboration with the research
community
19. POs experience of collaboration with researchers
20. Priorities and obstacles to the development of
research
21. Advances observed by the POs in different research areas (5
last years)
Major vs. important advances
Basic research 15% vs. 27%
Diagnosis 13% vs. 24%
Minor advances
Human and social sciences 40%
Assistive technologies 38%
Epidemiology 38%
22. Degree of priority that should be given when allocating
public funds & research areas
23. Obstacles to the advance of research
24. Conclusion
POs efforts for creating collectives of researchers, clinicians
& POs around the specific diseases they are concerned with
appears as being for them a priority action in the support /
development of research.
POs support to research concern a large range of research areas
(basic, therapeutic, social and human sciences).
Although financial support to research is the more visible form
of support, a large part of their involvement consist in activities
providing non-financial support to research.
POs have limited budgets, but rare disease research benefits
from their specific resources: contacts and trust between members
& their expertise on the diseases they are concerned with.